ZEUS System vs iCAC Device
AI Verdict
Choose ZEUS System if…
Choose ZEUS System if you require continuous, long-term ECG monitoring to detect and characterize intermittent or asymptomatic cardiac arrhythmias, such as Atrial Fibrillation. This tool is ideal for patients needing extended observation via wearable biosensors to capture elusive electrical abnormalities of the heart.
View ZEUS System →Choose iCAC Device if…
Choose iCAC Device if your primary goal is to opportunistically detect and quantify coronary artery calcium from existing routine chest CT scans to assess a patient's cardiovascular disease risk. This AI algorithm is best suited for leveraging readily available imaging data to identify early signs of atherosclerosis and inform preventative strategies.
View iCAC Device →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | ZEUS System | iCAC Device |
|---|---|---|
| Pricing | Not disclosed | Contact for pricing |
| Deployment | Cloud-based (AWS EC2 platform), no on-premise hardware. | Software as a Medical Device (SaMD), integrates with PACS or DICOM router. Cloud-based (via Carebricks platform). |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
ZEUS SystemThe ZEUS System, through its ZioSuite web portal and mobile app, offers a comprehensive, end-to-end solution for both clinicians and patients, streamlining patient enrollment, monitoring, and report interpretation. Its integration with wearable devices designed for patient comfort and compliance, along with robust EHR integration, provides a more holistic and user-friendly experience across the entire care pathway.
Clinical Value
ZEUS SystemBoth tools are FDA-cleared and offer significant clinical value in cardiac care. However, the ZEUS System provides long-term continuous ECG monitoring for up to 14 days, which is highly effective for detecting and characterizing both symptomatic and asymptomatic arrhythmias, supported by an extensive clinical library of over 135 scientific manuscripts.
Pricing & Value
ZEUS SystemWhile both tools do not publicly disclose their pricing, the ZEUS System (via iRhythm) offers more transparency regarding its billing model, including direct billing to patient insurance, financial assistance programs, and payment plans. This demonstrates a clearer effort to manage patient and provider financial burden and enhance accessibility.
Enterprise Readiness
ZEUS SystemThe ZEUS System explicitly states HIPAA compliance and the availability of a Business Associate Agreement (BAA), which are critical for enterprise adoption in healthcare. While Tool B integrates with key hospital systems, its compliance details require contacting the vendor, indicating less upfront transparency regarding these essential enterprise requirements.
Innovation
iCAC DeviceWhile both utilize AI innovatively, the iCAC Device stands out for its 'opportunistic identification' approach, leveraging AI to detect and quantify coronary artery calcium from *routine, non-contrast, non-gated chest CT scans* already performed for other reasons. This maximizes the value of existing data, enabling early cardiovascular disease detection without additional procedures or patient burden, representing a highly impactful innovation in clinical workflow.
Support & Docs
ZEUS SystemThe ZEUS System (iRhythm) provides comprehensive support and documentation, including a dedicated Clinical Resource Center, patient FAQs, patient advocates, and readily accessible Instructions for Use for both devices and software. This extensive support infrastructure is more explicitly detailed than for Tool B.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | ZEUS System | iCAC Device |
|---|---|---|
| Name | ZEUS System | iCAC Device |
| Company | iRhythm Technologies | Bunkerhill Health |
| Description | The ZEUS System by iRhythm Technologies is an AI-powered software that analyzes ECG data from wearable biosensors for long-term continuous cardiac monitoring, aiding in the detection and characterization of arrhythmias like Atrial Fibrillation. | Bunkerhill Health's iCAC Device is an FDA-cleared AI algorithm that detects and quantifies coronary artery calcium from routine, non-contrast, non-gated chest CT scans, aiding in early cardiovascular disease detection. |
| Key Functionality | AI-powered arrhythmia detection, Continuous ECG monitoring (up to 14 days), Detection and characterization of Atrial Fibrillation (AFib) | Estimates presence and quantity of coronary artery calcium (CAC), Analyzes routine, non-contrast, non-gated chest CT scans, Delivers exact and four-category quantitative estimates of CAC burden in Agatston units |
| Specialties | Cardiology, Family Medicine, Internal Medicine | Cardiology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring ZEUS System and iCAC Device.
Frequently Asked Questions
More Comparisons
More matchups featuring ZEUS System or iCAC Device
Backers
Who funded each tool's parent company.